Skip to main content

Table 3 The relative proportion by infection site (%), 2018–2021

From: Trending prevalence of healthcare-associated infections in a tertiary hospital in China during the COVID-19 pandemic

 

2018

2019

2020

2021

Total

Total

3060 (100)

2902 (100)

1754 (100)

1981 (100)

9697 (100)

RTI

1469 (48.01)

1373 (47.31)

695 (39.62)

775 (39.12)

4312 (44.47)

VAP

35 (1.14)

22 (0.76)

18 (1.03)

19 (0.96)

94 (0.97)

PCI

21 (0.69)

17 (0.59)

6 (0.34)

20 (1.01)

64 (0.66)

UTI

213 (6.96)

235 (8.1)

187 (10.66)

208 (10.5)

843 (8.69)

CAUTI

18 (0.59)

9 (0.31)

9 (0.51)

15 (0.76)

51 (0.53)

IAI

134 (4.38)

103 (3.55)

79 (4.5)

101 (5.1)

417 (4.3)

GI

152 (4.97)

171 (5.89)

130 (7.41)

133 (6.71)

586 (6.04)

OLI

8 (0.26)

2 (0.07)

1 (0.06)

6 (0.3)

17 (0.18)

DSSI

16 (0.52)

17 (0.59)

9 (0.51)

6 (0.3)

48 (0.49)

ICI

18 (0.59)

11 (0.38)

10 (0.57)

6 (0.3)

45 (0.46)

SST

129 (4.22)

95 (3.27)

76 (4.33)

69 (3.48)

369 (3.81)

OCI

99 (3.24)

114 (3.93)

77 (4.39)

77 (3.89)

367 (3.78)

CVS

19 (0.62)

11 (0.38)

7 (0.4)

11 (0.56)

48 (0.49)

BSI

373 (12.19)

348 (11.99)

181 (10.32)

222 (11.21)

1124 (11.59)

SSI

102 (3.33)

69 (2.38)

26 (1.48)

24 (1.21)

221 (2.28)

Others

254 (8.3)

305 (10.51)

243 (13.85)

289 (14.59)

1091 (11.25)

  1. BSI bloodstream infection, CAUTI catheter-associated urinary tract infection, CVS cardiovascular system infection, GI gastrointestinal infection, IAI intra-abdominal infection, ICI intracranial infection, OCI oral cavity infection, OLI organ lacuna infection, DSSI deep surgical site infection, PCI pleural cavity infection, RTI respiratory tract infection, SSI surgical site infection, SST skin and soft-tissue infection, UTI urinary tract infection, VAP ventilator-associated pneumonia